Recombinant HCV Core, NS3, NS4 and NS5 Protein, immunodominant regions |
VAng-0508Lsx-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Recombinant Hepatitis C virus antigen, contains the HCV core (aa 11-53), NS3 (aa 1210-1450, 1337-1483), NS4 (aa 1888-1925) and NS5 (aa 2332-2423) immunodominant regions, expressed in E. coli, MW 71 kDa. 0.80 mg/mL. |
Human IgG antibody Laboratories manufactures the spike protein s1 2 regions reagents distributed by Genprice. The Spike Protein S1 2 Regions reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Spike products are available in stock. Specificity: Spike Category: Protein Group: S1 2
Recombinant SARS-CoV-2 Spike S1 Protein with hFc and His-Tag |
EpiGentek |
100 ul |
EUR 518.1 |
Recombinant SARS-CoV-2 Spike S1 Protein with His and Avi Tag |
EpiGentek |
100 ul |
EUR 518.1 |
Rabbit Anti-Hepatitis B Surface Antigen Pres-S1+2 (HB-Pre-S1+2) IgG ELISA kit, 96 tests, quantitative |
Alpha Diagnostics |
1 Kit |
EUR 927.6 |
Monkey Anti-Hepatitis B Surface Antigen Pres-S1+2 (HB-Pre-S1+2) IgG ELISA kit, 96 tests, quantitative |
Alpha Diagnostics |
1 Kit |
EUR 927.6 |
S1 2 information
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
21-807 |
ProSci |
50 ug |
EUR 437.1 |
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells.The SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) is used as antigen in the Serological ELISA Kit to detect anti-SARS-CoV-2 Spike (RBD) antibodies in serum or plasma (see SARS-CoV-2 (Spike RBD) IgG Serological ELISA Kit; AG-45B-0020). |
Recombinant 2019-nCoV coronavirus Spike protein S1 subunit |
Spike-191V |
Creative BioMart |
100ug |
EUR 950.4 |
|
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to His tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV. |
Recombinant 2019-nCoV coronavirus Spike protein S1 subunit |
Spike-192V |
Creative BioMart |
100ug |
EUR 950.4 |
|
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to to Human IgG1 Fc tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV. |
Recombinant 2019-nCoV coronavirus Spike protein S1 subunit |
Spike-193V |
Creative BioMart |
100ug |
EUR 1932 |
|
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to to Mouse IgG1 Fc tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV. |
SARS-CoV-2 Spike S1 (13-665) Protein, Fc Fusion, Avi-tag |
E80020 |
EpiGentek |
|
|
SARS-CoV-2 Spike S1 (16-685) Protein, Fc Fusion, Avi-tag |
E80022 |
EpiGentek |
|
|
Spike S1 RBD-Nucleocapsid Protein Chimera (SARS-CoV-2) |
100938-1 |
BPS Bioscience |
20 µg |
EUR 420 |
Description: SARS-CoV-2 Spike protein S1 subunit, receptor binding domain (Spike S1 RBD), GenBank Accession No. MN908947, a.a. 319-541, fused with HSA to SARS-CoV-2 Nucleocapsid protein (N-protein), GenBank Accession No. QHD43423, a.a 237-419, with C-terminal His-tag, Expressed in CHO cells. MW=130 kDa. |
Spike S1 RBD-Nucleocapsid Protein Chimera (SARS-CoV-2) |
100938-2 |
BPS Bioscience |
50 µg |
EUR 555 |
Description: SARS-CoV-2 Spike protein S1 subunit, receptor binding domain (Spike S1 RBD), GenBank Accession No. MN908947, a.a. 319-541, fused with HSA to SARS-CoV-2 Nucleocapsid protein (N-protein), GenBank Accession No. QHD43423, a.a 237-419, with C-terminal His-tag, Expressed in CHO cells. MW=130 kDa. |
Spike S1 RBD-Nucleocapsid Protein Chimera (SARS-CoV-2) |
100938-3 |
BPS Bioscience |
100 µg |
EUR 740 |
Description: SARS-CoV-2 Spike protein S1 subunit, receptor binding domain (Spike S1 RBD), GenBank Accession No. MN908947, a.a. 319-541, fused with HSA to SARS-CoV-2 Nucleocapsid protein (N-protein), GenBank Accession No. QHD43423, a.a 237-419, with C-terminal His-tag, Expressed in CHO cells. MW=130 kDa. |
SARS-CoV-2 Spike S1 RBD Protein, Avi-His-tag |
E80024 |
EpiGentek |
|
|
SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion |
E80026 |
EpiGentek |
|
|
Mouse monoclonal Anti-MERS Spike protein (S1/18-725aa) IgG (clone 2) |
MERS124-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Recombinant Coronavirus Spike Protein (MERS-CoV S1; 56-295) |
P1514-10 |
Biovision |
10µg |
EUR 187.2 |
Recombinant Coronavirus Spike Protein (MERS-CoV S1; 56-295) |
P1514-50 |
Biovision |
50µg |
EUR 661.2 |
Recombinant 2019-nCoV coronavirus Spike protein, S1+S2 ECD |
Spike-194V |
Creative BioMart |
100ug |
EUR 1932 |
|
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein (S1+S2 ECD) was fused to His-tag at C-terminus and expressed in Baculovirus-Insect cell. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell.S1 mainly contains a receptor binding domain (RBD) and recognize the cell surface receptor. S2 essential for membrane fusion. S protein are important for neutralizing-antibody and T-cell responses, as well as protective immunity. |
Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; S1), Recombinant |
P1524-10 |
Biovision |
10 µg |
EUR 332.4 |
Recombinant SARS-CoV-2 Spike S1 Protein with His and Avi Tag |
E80003-1 |
EpiGentek |
100 ul |
EUR 518.1 |